Got brain? Neural mechanisms play role in healthy bone growth

April 23, 2007

Scientists searching for a gene therapy to control obesity have unexpectedly discovered a way that the brain regulates bone growth, a finding that shines new light on osteoporosis and other bone-robbing diseases.

Researchers from the University of Florida’s McKnight Brain Institute transferred the gene to produce leptin — a hormone that has been linked with appetite control, obesity and diabetes — into the brains of mice that, because of a genetic defect, are leptin-deficient and obese.

The gene transfer not only helped the mice lower their body weight, it unexpectedly increased bone growth and normalized their bone volume, adding or reducing it as needed, according to UF and Oregon State University researchers.

The findings, to be published this week in the journal Peptides, advance efforts to use gene therapy to treat human obesity while underscoring the importance of the brain in matters more often associated with nutrition. This is the first study to show that without leptin in the brain, bones do not grow properly.

“Everyone naturally thinks about calcium and the foods that we eat in regard to strong bones, and while that is very important, it seems ultimately the brain plays an integral role in the development and growth of bones,” said Satya P. Kalra, a distinguished professor of neuroscience in the UF College of Medicine. “It appears that you can use gene therapy to provide leptin continuously in the brain to promote bone growth. We still have to do more experiments, but I was surprised that the effects thus far would be so robust.”

The findings provide a new outlook on diseases such as osteoporosis, which is estimated to contribute to 2 million bone fractures annually in the United States. Discovering ways to enhance bone accumulation during early growth is important for preventing osteoporosis later in life, the researchers said.

“On the basis of previously published research, we expected the gene therapy to result in bone loss — we thought that osteoporosis would be a potential negative side effect of the treatment,” said Urszula T. Iwaniec, an assistant professor of nutrition and exercise sciences at Oregon State University and the lead author of the research. “But when we increased leptin in the brain, we saw increased bone growth and normalization of bone mass. Bone that was abnormally low or abnormally high became normal and the skeletons of these mice no longer differed from normal healthy mice. This indicates that leptin is essential for normal bone health.”

The researchers concentrated on restoring the leptin in the hypothalamus in the brain, not leptin produced by fat cells and readily circulated in the bloodstream.

Researchers injected a virus carrying the leptin gene into the brains of leptin-deficient young mice. Inability to produce leptin causes extreme obesity, shorter-than-normal leg bones and excess volume in the spongy bone of the vertebrae.

The virus “infected” the brain cells with the ability to produce the hormone, resulting in mice that weighed half what the leptin-deficient mice usually weigh. In addition, their bone growth resembled that of normal mice.

“The question of whether the brain regulates bone growth has been highly debated, so this is an important contribution because the researchers normalized bone growth by targeting the brain,” said Mark Hamrick, an associate professor of cellular biology and anatomy at the Medical College of Georgia who was not involved in the research. “They’ve also taken a very novel approach, using a virus to increase expression of leptin in the hypothalamus.”

Source: University of Florida

Explore further: Gene therapy could aid weight loss without affecting bone loss

Related Stories

Gene therapy could aid weight loss without affecting bone loss

October 21, 2015
Delivering the hormone leptin directly to the brain through gene therapy aids weight loss without the significant side effect of bone loss, according to new collaborative research from Oregon State University and University ...

Bone-derived hormone suppresses appetite in mice

March 8, 2017
A hormone secreted by bone cells can suppress appetite, according to mouse studies conducted by Columbia University Medical Center (CUMC) researchers. The hormone—called lipocalin 2—turns on neurons in the brain that ...

Of brains and bones: How hunger neurons control bone mass

September 24, 2015
In an advance that helps clarify the role of a cluster of neurons in the brain, Yale School of Medicine researchers have found that these neurons not only control hunger and appetite, but also regulate bone mass.

The new skinny on leptin

September 26, 2012
(Medical Xpress)—Leptin—commonly dubbed the "fat hormone"—does more than tell the brain when to eat. A new study by researchers at The University of Akron and Northeast Ohio Medical University (NEOMED) shows that leptin ...

Understanding the fascinating interaction between bone and brain

October 31, 2016
"The best news is that the brain has become front and centre in the regulation of bone modelling", conclude authors Professors Paul Dimitri and Cliff Rosen in their concise review of the complex role of the central nervous ...

Proteins causing daytime sleepiness tied to bone formation, target for osteoporosis

June 12, 2014
Orexin proteins, which are blamed for spontaneous daytime sleepiness, also play a crucial role in bone formation, according to findings by UT Southwestern Medical Center researchers. The findings could potentially give rise ...

Recommended for you

Hibernating ground squirrels provide clues to new stroke treatments

November 17, 2017
In the fight against brain damage caused by stroke, researchers have turned to an unlikely source of inspiration: hibernating ground squirrels.

Age and gut bacteria contribute to multiple sclerosis disease progression

November 17, 2017
Researchers at Rutgers Robert Wood Johnson Medical School published a study suggesting that gut bacteria at young age can contribute to multiple sclerosis (MS) disease onset and progression.

Molecular guardian defends cells, organs against excess cholesterol

November 16, 2017
A team of researchers at the Harvard T. H. Chan School of Public Health has illuminated a critical player in cholesterol metabolism that acts as a molecular guardian in cells to help maintain cholesterol levels within a safe, ...

Prototype ear plug sensor could improve monitoring of vital signs

November 16, 2017
Scientists have developed a sensor that fits in the ear, with the aim of monitoring the heart, brain and lungs functions for health and fitness.

Ancient enzyme could boost power of liquid biopsies to detect and profile cancers

November 16, 2017
Scientists are developing a set of medical tests called liquid biopsies that can rapidly detect the presence of cancers, infectious diseases and other conditions from only a small blood sample. Researchers at The University ...

FDA to crack down on risky stem cell offerings

November 16, 2017
U.S. health authorities announced plans Thursday to crack down on doctors pushing stem cell procedures that pose the gravest risks to patients amid an effort to police a burgeoning medical field that previously has received ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.